Earnings Feed
Start Free
Home/Insiders/Shah Pritesh
SP
SEC Insider//CIK 0001744884

Shah Pritesh

CIK 00017448841 companyMALVERN, PA
SEC Profile

Transactions

50

Companies

1

Filings

11

CIK

0001744884

Recent Transactions

50 trades
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-11-07$12.65/sh−382→ 124,511 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-09-01$21.82/sh−273→ 124,893 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-06-30$35.28/sh+367→ 125,166 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+43,246→ 146,220 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−2,942→ 141,708 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+3,936→ 102,974 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−1,570→ 144,650 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−16,909→ 124,799 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$75.28/sh−937→ 99,038 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-01$76.36/sh−1,923→ 99,975 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-02-28$76.97/sh+31,691→ 31,691 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-02-28+19,055→ 101,898 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−387→ 82,843 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-09-02$79.04/sh−269→ 83,230 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-07-05$59.08/sh+312→ 83,499 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-09$71.19/sh−3,669→ 83,187 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-08$70.10/sh−2,481→ 81,908 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-07$69.55/sh−5,294→ 84,389 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-04$73.34/sh−2,632→ 91,597 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-04$70.41/sh−1,914→ 89,683 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+6,231→ 6,231 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+38,027→ 38,027 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$74.50/sh−997→ 94,229 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03+21,714→ 95,226 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-09-03$139.24/sh−150→ 73,542 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-09-03$138.27/sh−321→ 73,692 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-09-03$140.18/sh−30→ 73,512 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-09-02$138.23/sh−156→ 74,013 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-08-04$148.71/sh−2,063→ 74,169 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-08-03$149.43/sh−1,654→ 76,232 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2021-07-31−3,717→ 3,717 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-07-31$154.01/sh+3,717→ 85,625 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-07-06$137.12/sh+154→ 77,886 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-06-10$215.00/sh−23,540→ 77,732 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-05$199.67/sh−1,290→ 101,272 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-04$200.86/sh−1,043→ 102,562 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2021-05-03−2,333→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-03$204.10/sh+2,333→ 103,605 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-09$131.09/sh−3,524→ 101,272 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-08$130.81/sh−2,627→ 104,796 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-03-05−13,987→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-03-05$7.15/sh+13,987→ 111,973 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-03-05$131.53/sh−4,550→ 107,423 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-04$137.55/sh−2,658→ 97,986 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-03$150.78/sh−2,174→ 100,644 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-03-02+20,004→ 20,004 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-02+10,886→ 102,818 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-02$152.05/sh−912→ 91,932 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2021-02-27−3,086→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-02-27$149.10/sh+3,086→ 92,844 total

Companies

1

Recent Filings

11

Address

C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300

MALVERN, PA, 19355

View on SEC.gov